Alain Vigroux
Paul Sabatier University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Alain Vigroux.
Organic and Biomolecular Chemistry | 2008
Christelle Dupouy; Iché-Tarrat N; Marie-Pierre Durrieu; Alain Vigroux; Jean-Marc Escudier
Introduction of alpha,beta-D-CNA featuring canonical values of the torsional angles alpha and beta within oligonucleotides leads to an overall stabilization and improved rigidity of the duplex DNA as demonstrated by UV experiments, circular dichroism and corroborated by molecular dynamics simulations.
Journal of Physical Chemistry B | 2008
Nathalie Iché-Tarrat; Jean-Claude Barthelat; Alain Vigroux
It has been proposed that the driving force for the initial phosphoryl transfer step of protein tyrosine phosphatases (PTPases) could be activation of the substrate ROPO32- by means of an enforced hydrogen-bonding interaction between an aspartic general acid and the bridging oxygen atom O (Zhang et al. Biochemistry 1995, 34, 16088-16096). The potential catalytic effect of this type of interaction, with regard to P-OR bond cleavage, was investigated computationally through simple model systems in which an efficient intramolecular hydrogen bond can take place between a H-bond donor group and the bridging oxygen atom of the dianionic phosphate. The dielectric effect of the environment (epsilon = 1, 4, and 78) was also explored. The results indicate that this interaction causes significant lengthenings of the scissile P-OR bond in all media but with more extreme effects observed in the low dielectric fields epsilon = 1 and epsilon = 4. It is interesting that, in all cases examined, this interaction actually contributes to stabilize the reactant state while causing its P-OR bond to lengthen. Overall, our results support the idea that this specific hydrogen-bonding situation might well be used by PTPases as an important driving force for promoting phosphoryl transfer reactions through highly dissociative transition states.
Bioorganic & Medicinal Chemistry Letters | 1995
Alain Vigroux; Michel Bergon
Abstract A series of alkyl and aryl N-(5-chloro-2-hydroxyphenyl)carbamates, prodrugs of chlorzoxazone, have been synthesized. The synthesis in a five-step process of one of them, 4-acetamidophenyl ester, a mutual prodrug of chlorzoxazone and acetaminophen, is described.
Biochemical Pharmacology | 1991
Faouzi Lakhdar-Ghazal; Alain Vigroux; Michèle Willson; Jean-François Tocanne; Jacques Périé; Jean-Charles Faye
Amphiphilic diphenyl methane derivatives exhibiting both antiproliferative and trypanocidal effects were studied with respect to their interactions with phospholipids, in monolayers and bilayers. These compounds, namely (4-benzyl)-phenoxy-2 trimethylammonium ethane iodide (D1), (4-tertiobutyl)-phenoxy-2 morpholinium ethane chloride (D2), and (4-benzyl)-phenoxy-2 morpholinium ethane chloride (D3), were shown to interact with phosphatidylcholine (PC) and phosphatidylserine (PS) in monolayers, as monitored by surface pressure and surface potential measurements. The film expansion of monolayers, on 10 mM NaCl subphase at pH 7.1, was more pronounced in the presence of D2 and D3 in the subphase before spreading of the lipids than with the injection of the drugs underneath a preformed film. Apparent binding constants of 10(4) M-1 were determined for both drugs from monolayer experiments. With D2 in the presence of PS, results of monolayer compressions and electrophoretic mobility measurements indicate binding of the drug to the lipid molecules only when the molecular area was large. D3 was shown to interact with PS, both in monolayers and bilayers, with a drug-to-lipid binding constant of about 2 x 10(4)M-1, as evaluated from electrophoretic mobility measurements on PS liposomes. These results, which indicate binding of these drugs to phospholipids in the order D2 less than D3, correlate with the biological activity of the drugs, and may account for the discrepancy observed between the drug concentrations required for biological and binding activities.
Journal of Medicinal Chemistry | 1995
Alain Vigroux; Michel Bergon; Chantal Zedde
Angewandte Chemie | 2006
Christelle Dupouy; Nathalie Iché-Tarrat; Marie-Pierre Durrieu; Frédéric Rodriguez; Jean-Marc Escudier; Alain Vigroux
Journal of Physical Chemistry B | 2005
Nathalie Iché-Tarrat; Jean-Claude Barthelat; and Daniel Rinaldi; Alain Vigroux
Journal of Organic Chemistry | 2005
Ingrid Le Clézio; Heinz Gornitzka; Jean-Marc Escudier; Alain Vigroux
Chemistry: A European Journal | 2007
Nathalie Iché-Tarrat; Manuel F. Ruiz-López; Jean-Claude Barthelat; Alain Vigroux
Journal of the American Chemical Society | 2002
Marc Bianciotto; Jean-Claude Barthelat; Alain Vigroux